MBX Biosciences, Inc. Common Stock

MBX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$223,125$39,781$29,903$49,351
Short-Term Investments$168,548$185,125$210,883$212,798
Receivables$0$841$1,385$682
Inventory$0$0$0$0
Other Curr. Assets$5,829$3,443$2,105$4,455
Total Curr. Assets$397,502$229,190$244,276$267,286
Property Plant & Equip (Net)$2,524$2,281$1,600$1,199
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$50$50$50$50
Total NC Assets$2,574$2,331$1,650$1,249
Other Assets$0$1$0$0
Total Assets$400,076$231,522$245,926$268,535
Liabilities
Payables$3,768$5,764$4,245$5,335
Short-Term Debt$154$138$130$171
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$8,140$5,854$6,106$5,545
Total Curr. Liab.$12,062$11,756$10,481$11,051
LT Debt$469$512$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$7$15$23$42
Total NC Liab.$476$527$23$42
Other Liabilities$0$0$0$0
Cap. Leases$623$650$130$171
Total Liabilities$12,538$12,283$10,504$11,093
Equity
Pref Stock$0$0$0$0
Common Stock$6$5$5$5
Retained Earnings-$202,414-$180,796-$161,385-$137,505
AOCI$154$11$53$55
Other Equity$589,792$400,019$396,749$394,887
Total Equity$387,538$219,239$235,422$257,442
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$400,076$231,522$245,926$268,535
Net Debt-$222,502-$39,131-$29,773-$49,180